Cellectis bioresearch Company Profile

22:02 EST 17th November 2017 | BioPortfolio

Cellectis bioresearch was incorporated as a subsidiary of Cellectis SA (Alternext: ALCLS) in June 2008. It provides life science researchers with ready-to-use research tools for genome customization. These tools, based on meganucleases, enable the customization of cells with optimized features for drug discovery, protein production and gene function study.

News Articles [114 Associated News Articles listed on BioPortfolio]

Cellectis Granted T Cell CRISPR Patent in Europe

The bitter patent feud over CRISPR , a gene-editing tool with unprecedented potential, continues in the United States. Meanwhile, French biotech Cellectis is staking a claim to the technology in Europ...

FDA Lifts Hold on Cellectis’s “Off the Shelf” CAR-T, With Caveats

The FDA has cleared Cellectis to resume testing an experimental “off the shelf” type of cell therapy, so long as it follows a new set of measures meant to quell the safety concerns that caused the...

Cellectis given another shot at off-the-shelf CAR-T

It is easy to forget the very real dangers that CAR-T treatment present to patients after Novartis and Gilead both successfully scored approvals on the back of impressive data, and with Juno Therapeut...

The dawn of a new beginning for Cellectis?

Paris – amazingly it’s now 3 years since we interviewed Cellectis (NASDAQ: $CLLS) CEO André Choulika and CSO Philippe Duchateau…

House oversight subcommittee reports on safety of bioresearch labs

The House Energy and Commerce Subcommittee on Oversight and Investigations has released a report on its investigation of allegations that a bioresearch lab in Maryland mishandled vials of smallpox. Re...

Cellectis advances CAR-T therapy study with dosing of its first participant

The early-stage clinical trial that will evaluate the efficacy and safety of UCART123, Cellectis' chimeric antigen receptor T -More- 

Death Of First CAR-T Patient Forces Trial Halt For Cellectis

ENDPOINTS NEWS |  The FDA has forced Cellectis to slam the brakes on two clinical trials of its off-the-shelf-version of a CAR-T therapy after their first patient was killed by a lethally toxic react...

Cellectis doses first patient with BPDCN in phase I study of UCART123

Cellectis, a clinical─stage biopharmaceutical company focused on developing immunotherapies based on gene─edited CAR T─cells (UCART), announced that the first patient with Blastic Plasmacytoid

Drugs and Medications [0 Results]


PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Arginine-modified dual emission photoluminescent nanocrystals for bioimaging at subcellular resolution.

Bioimaging at a subcellular resolution to label cytoplasm and nucleus in living cell by just one photoluminescent nanoparticle has great application potential in bioresearch, preclinical diagnosis, sc...

Clinical Trials [0 Results]


Companies [16 Associated Companies listed on BioPortfolio]

Cellectis bioresearch

Cellectis bioresearch was incorporated as a subsidiary of Cellectis SA (Alternext: ALCLS) in June 2008. It provides life science researchers with ready-to-use research tools for genome customization. ...


Cellectis is a pioneer in the field of genome engineering. The company designs and markets innovative tools, meganucleases. These molecular scissors enable targeted modifications ...

Cellectis Group

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...

BioResearch Online

Welcome to BioResearch Online, the premier Internet source of useful and timely information for the worldwide bioresearch and life sciences industries. This site is designed to serve the needs of labo...

Cellectis S.A.

Cellectis S.A. is a world leader in genome engineering and genome surgery. The company focuses on developing and producing custom meganucleases for use in in vivo genome surgery a...

More Information about "Cellectis bioresearch" on BioPortfolio

We have published hundreds of Cellectis bioresearch news stories on BioPortfolio along with dozens of Cellectis bioresearch Clinical Trials and PubMed Articles about Cellectis bioresearch for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cellectis bioresearch Companies in our database. You can also find out about relevant Cellectis bioresearch Drugs and Medications on this site too.

Quick Search

Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record